Tag: M&A

AbbVie Acquired Mavupharma Enhancing Early Stage Oncology Pipeline

AbbVie announced that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for ...

Imugene to Acquire Vaxinia and Exclusive License to Oncolytic Virus Technology

Australian immuno-oncology company Imugene Ltd., announced that it would acquire Vaxinia Pty Ltd and separately acquire a worldwide exclusive license to a promising oncolytic virus technology, known a...

Boehringer Ingelheim Announced Acquisition of AMAL Therapeutics

boehringer
Boehringer Ingelheim announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic can...

Altimmune Definitively Agreed to Acquire Spitfire Pharma

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has entered into an agreement to acquire Spitfire Pharma, Inc. (Spitfire) including its product candidate SP-1373 (to be ...

EnPro Industries Acquires The Aseptic Group

EnPro Industries, Inc., a leading manufacturer of engineered industrial products, announced it has acquired The Aseptic Group (comprising Aseptic Process Equipment SAS and Aseptic Services SARL), a pr...

ZYUS to Acquire Healthcare Technology Company

ZYUS Life Sciences Inc. (“ZYUS”) announced that it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”) in a share for shar...

Altimmune to Acquire Spitfire with its NASH Drug

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has entered into an agreement to acquire Spitfire Pharma, Inc. (Spitfire) including its product candidate SP-1373 (to be ...

Roche Extends Deadline for Acquisition of Spark Therapeutics by Three Months

Roche disclosed Monday in a filing with the US Securities and Exchange Commission that it will extend the deadline for closing its $4.3-billion acquisition of Spark Therapeutics by three months. Roche...

Pfizer Completed Acquisition of Biotechnology Company Therachon Holding AG

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction, Pfizer acquired ...

Acquisition of Xellera Therapeutics Completed by Novoheart Holdings

Novoheart Holdings Inc. announced that it has completed its previously announced acquisition of all of the shares of Xellera Therapeutics Limited. As consideration for the Acquisition, Novoheart has i...

AbbVie to Acquire Allergan for $63bn

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transactio...

BMS Provides Update on Celgene’s Merger

Bristol-Myers Squibb Company provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in discussions with...

Halo Labs to Acquire Bophelo Bioscience

Halo Labs Inc. announced that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd. The Transaction is expected to st...

Pfizer to Acquire Biopharmaceutical Company Array BioPharma

Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused on ...

Eton Pharmaceuticals to Acquire U.S. Marketing Rights for ET-105

research
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that the Company has entered into an agreement with Aucta P...

Sobi Buys Rare-Disease Drug Emapalumab

Rare diseases specialist Swedish Orphan Biovitrum (Sobi) has agreed to buy the drug emapalumab and is reorganizing to increase focus on late-stage development in hematology and immunology. The drug...